Types of Cerebral Amyloid Angiopathy (CAA)
Cerebral amyloid angiopathy (CAA) is classified into several distinct types based on the specific amyloid protein deposited in the cerebrovascular walls, with sporadic Aβ-type CAA being the most common form in older individuals.
Primary Classification of CAA Types
Based on Amyloid Protein Type:
Aβ-type CAA (most common)
Sporadic Aβ-type CAA
- Typically affects elderly individuals
- Associated with aging and Alzheimer's disease
- ApoE ε4 allele is a significant risk factor 1
Hereditary/Familial Aβ-type CAA
Non-Aβ CAA types (less common, hereditary forms)
Cystatin C-related CAA
Transthyretin (TTR)-related CAA
Gelsolin-related CAA
Prion protein-related CAA
BRI2 gene-related CAA
Morphological Classification of Sporadic Aβ-type CAA:
CAA-Type 1
- Characterized by Aβ deposition in:
- Cortical capillaries
- Leptomeningeal and cortical arteries
- Arterioles, veins, and venules
- Strongly associated with ApoE ε4 allele (4x higher frequency)
- Features capillary involvement ("dyshoric angiopathy") 5
- Characterized by Aβ deposition in:
CAA-Type 2
- Aβ deposition in:
- Leptomeningeal and cortical vessels
- Notably spares cortical capillaries
- Higher frequency of ApoE ε2 allele
- Does not involve capillaries 5
- Aβ deposition in:
Clinical Significance and Complications
CAA can lead to several serious complications:
Hemorrhagic lesions
- Lobar intracerebral macrohemorrhage
- Cortical microhemorrhage
- Cortical superficial siderosis/focal convexity subarachnoid hemorrhage 4
Ischemic lesions
- Cortical infarction
- White matter ischemic changes 4
Inflammatory manifestations
Cognitive impairment and dementia
- Often coexists with Alzheimer's disease pathology 6
Special Considerations
Early-onset CAA requires specific investigation for genetic causes or rare acquired forms, including iatrogenic subtypes 2
CAA-related inflammation shares pathophysiology with amyloid-related imaging abnormalities (ARIA) seen in patients receiving amyloid-modifying therapies 1, 4
Diagnostic approaches now include advanced neuroimaging techniques:
- Gradient-echo T2* and susceptibility-weighted imaging for detecting microhemorrhages
- Amyloid PET imaging (though it cannot distinguish vascular from parenchymal amyloid) 4
Genetic risk factors play important roles in both sporadic and hereditary forms:
- ApoE ε4 increases vascular Aβ deposition
- ApoE ε2 is associated with CAA-related hemorrhage 7
Understanding the specific type of CAA is crucial for proper management, risk assessment, and potential therapeutic approaches, particularly as amyloid-modifying therapies continue to be developed for Alzheimer's disease.